山外山(688410.SH):美國關稅政策對公司現有銷售業務無任何影響
格隆匯4月7日丨山外山(688410.SH)在互動平臺表示,關於美國加徵關稅政策對公司的影響,基於當前山外山公司經營情況,現說明如下: 一、美國關稅政策不影響公司國際銷售業務公司尚未涉足美國市場銷售。當前公司海外業務聚焦高成長性新興市場,2024年已公開數據顯示(公司三季報):公司計劃在鞏固亞太地區血透設備的高增長勢頭的同時,大力發展南美、非洲、歐洲市場,藉助海外智能大數據平臺和售後服務體系,構建以東南亞、非洲、南美、歐洲爲中心的市場格局。因此,美國關稅政策對公司現有銷售業務無任何影響。 二、美國關稅政策不影響公司供應鏈 公司所有原材料不涉及美國採購。經過二十餘年的深入發展,公司已成功打造了涵蓋“主要原材料-核心部件-整機制造”的國產化供應鏈,完全實現了自主可控。 三、核心自主知識產權護航公司可持續發展公司研發投入連續三年平均增長率爲45%,公司已擁有發明專利58項(其中國內發明專利52項,國外發明專利6項),實用新型專利98項,外觀設計專利35項,軟件著作權47項,其他148項;已獲得三類醫療器械證註冊證12項,多個產品已獲CE認證證書。 公司建設了智能製造大數據中心、醫療大數據中心和血液淨化遠程運維大數據中心三大平臺。通過“血液淨化設備、血液淨化耗材、血液淨化智能管理系統”戰略,已形成覆蓋設備+患者+醫護+遠程運維全產業鏈數字化、智能化解決方案。技術實力雄厚,爲公司高質量發展持續蓄勢賦能。 基於上述紮實佈局,美國關稅政策對公司2025年採購和營收均無任何影響。公司將秉持“技術驅動+全球視野”發展理念,持續爲股東創造穩健回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.